BioAegis Therapeutics receives approval to proceed with phase 2 trial of its gelsolin Covid-19 treatment

BioAegis Therapeutics has received approval to proceed with phase 2 trial of its gelsolin Covid-19 treatment. (Credit: Pete Linforth from Pixabay)